tricalcium phosphate has been researched along with HIV Coinfection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardier, A; Daudon, M; Izzedine, H; M'rad, MB; Salmon, D | 1 |
| Bajpai, PK; Cannon, MR | 1 |
| Everitt, L; Kaplan, AH; Manchester, M; Swanstrom, R | 1 |
4 other study(ies) available for tricalcium phosphate and HIV Coinfection
| Article | Year |
|---|---|
Atazanavir crystal nephropathy.
Topics: Atazanavir Sulfate; Calcium Phosphates; Crystallization; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Calculi; Male; Middle Aged; Oligopeptides; Pyridines | 2007 |
Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
Topics: Animals; Calcium Phosphates; Ceramics; Drug Delivery Systems; Durapatite; HIV Infections; Humans; In Vitro Techniques; Materials Testing; Rats; Rats, Sprague-Dawley; Zidovudine | 1995 |
Analysis of human immunodeficiency virus type 1 protease activity in eukaryotic and bacterial cells.
Topics: Calcium Phosphates; Cell Line, Transformed; DNA, Recombinant; Escherichia coli; Gene Expression Regulation, Enzymologic; Gene Products, gag; Gene Products, pol; HeLa Cells; HIV Infections; HIV Protease; HIV-1; Humans; Immune Sera; Precipitin Tests; Protein Precursors; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Safety; T-Lymphocytes | 1994 |
Anecdotal reports: elderberry extract plus chondroitin and glucosamine sulfate and Thy-mate reduces viral load to non-detectable levels in 10 days.
Topics: AIDS-Related Opportunistic Infections; Calcium Phosphates; Chondroitin Sulfates; Complementary Therapies; Drug Synergism; Drug Therapy, Combination; Glucosamine; HIV Infections; HIV Protease Inhibitors; Humans; Plant Extracts; Pneumonia, Pneumocystis; Viral Load | 1998 |